Log in

NASDAQ:HSICHenry Schein Stock Price, Forecast & News

$60.72
-0.73 (-1.19 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$59.93
Now: $60.72
$61.59
50-Day Range
$51.13
MA: $54.00
$62.24
52-Week Range
$41.85
Now: $60.72
$73.99
Volume2.62 million shs
Average Volume1.76 million shs
Market Capitalization$8.67 billion
P/E Ratio12.47
Dividend YieldN/A
Beta0.95
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners, and animal health clinics. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners. The company was founded in 1932 and is headquartered in Melville, New York.
Read More
Henry Schein logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 1.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 3.1 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.39 out of 5 stars


Industry, Sector and Symbol

Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
Current SymbolNASDAQ:HSIC
CUSIP80640710
Phone631-843-5500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$9.99 billion
Cash Flow$4.77 per share
Book Value$25.26 per share

Profitability

Net Income$694.73 million

Miscellaneous

Employees19,000
Market Cap$8.67 billion
Next Earnings Date8/4/2020 (Estimated)
OptionableOptionable

Receive HSIC News and Ratings via Email

Sign-up to receive the latest news and ratings for HSIC and its competitors with MarketBeat's FREE daily newsletter.

Henry Schein (NASDAQ:HSIC) Frequently Asked Questions

How has Henry Schein's stock been impacted by COVID-19 (Coronavirus)?

Henry Schein's stock was trading at $57.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, HSIC stock has increased by 5.3% and is now trading at $60.72. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Henry Schein?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 3 sell ratings, 8 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Henry Schein.

When is Henry Schein's next earnings date?

Henry Schein is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Henry Schein.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) announced its earnings results on Tuesday, May, 5th. The company reported $0.94 earnings per share for the quarter, topping analysts' consensus estimates of $0.74 by $0.20. The business earned $2.43 billion during the quarter, compared to analyst estimates of $2.32 billion. Henry Schein had a return on equity of 15.19% and a net margin of 7.11%. The company's revenue for the quarter was up 2.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.80 EPS. View Henry Schein's earnings history.

When did Henry Schein's stock split? How did Henry Schein's stock split work?

Shares of Henry Schein split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were payable to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of Henry Schein stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein declared that its Board of Directors has initiated a stock buyback plan on Thursday, October 31st 2019, which permits the company to repurchase $400,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to purchase up to 4.3% of its stock through open market purchases. Stock repurchase plans are generally a sign that the company's board believes its shares are undervalued.

What price target have analysts set for HSIC?

14 equities research analysts have issued 12-month target prices for Henry Schein's stock. Their forecasts range from $50.00 to $80.00. On average, they anticipate Henry Schein's stock price to reach $63.73 in the next twelve months. This suggests a possible upside of 5.0% from the stock's current price. View analysts' price targets for Henry Schein.

Has Henry Schein been receiving favorable news coverage?

Media coverage about HSIC stock has been trending somewhat negative this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Henry Schein earned a news impact score of -1.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutHenry Schein.

Who are some of Henry Schein's key competitors?

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), AbbVie (ABBV), AT&T (T), Walt Disney (DIS), Pfizer (PFE), Intel (INTC), NVIDIA (NVDA), salesforce.com (CRM), Cisco Systems (CSCO) and UnitedHealth Group (UNH).

Who are Henry Schein's key executives?

Henry Schein's management team includes the following people:
  • Mr. Stanley M. Bergman, Exec. Chairman & CEO (Age 69)
  • Mr. James P. Breslawski, Vice Chairman & Pres (Age 65)
  • Mr. Steven Paladino, Exec. VP, CFO & Exec. Director (Age 62)
  • Mr. Gerald A. Benjamin, Exec. VP, Chief Admin. Officer & Director (Age 66)
  • Mr. Mark E. Mlotek, Exec. VP, Chief Strategic Officer & Director (Age 63)

What is Henry Schein's stock symbol?

Henry Schein trades on the NASDAQ under the ticker symbol "HSIC."

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of institutional and retail investors. Top institutional investors include Longview Partners Guernsey LTD (10.22%), BlackRock Inc. (8.41%), State Street Corp (5.36%), Mackenzie Financial Corp (2.30%), Atlanta Capital Management Co. L L C (1.90%) and JPMorgan Chase & Co. (1.87%). Company insiders that own Henry Schein stock include David Mckinley, E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Mark E Mlotek, Michael S Ettinger, Paul Brons, Philip A Laskawy, Stanley M Bergman, Steven Paladino and Walter Siegel. View institutional ownership trends for Henry Schein.

Which institutional investors are selling Henry Schein stock?

HSIC stock was sold by a variety of institutional investors in the last quarter, including Atlanta Capital Management Co. L L C, APG Asset Management N.V., APG Asset Management N.V., APG Asset Management N.V., AMI Asset Management Corp, Boston Trust Walden Corp, Mackenzie Financial Corp, and Boston Trust Walden Corp. Company insiders that have sold Henry Schein company stock in the last year include E Dianne Rekow, Gerald A Benjamin, James P Breslawski, Michael S Ettinger, Paul Brons, Stanley M Bergman, Steven Paladino, and Walter Siegel. View insider buying and selling activity for Henry Schein.

Which institutional investors are buying Henry Schein stock?

HSIC stock was bought by a variety of institutional investors in the last quarter, including Sound Shore Management Inc. CT, BlackRock Inc., Fiduciary Management Inc. WI, AXA, State of Tennessee Treasury Department, Acadian Asset Management LLC, Bank of New York Mellon Corp, and New York State Common Retirement Fund. View insider buying and selling activity for Henry Schein.

How do I buy shares of Henry Schein?

Shares of HSIC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Henry Schein's stock price today?

One share of HSIC stock can currently be purchased for approximately $60.72.

How big of a company is Henry Schein?

Henry Schein has a market capitalization of $8.67 billion and generates $9.99 billion in revenue each year. The company earns $694.73 million in net income (profit) each year or $3.51 on an earnings per share basis. Henry Schein employs 19,000 workers across the globe.

What is Henry Schein's official website?

The official website for Henry Schein is www.henryschein.com.

How can I contact Henry Schein?

Henry Schein's mailing address is 135 DURYEA RD, MELVILLE NY, 11747. The company can be reached via phone at 631-843-5500 or via email at [email protected]

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.